GEN in the 13F filings
Nortonlifelock Inc · CUSIP 668771108
- Quarter end
- 31 Dec 2024
- the date the book describes
- Filed
- 5 Nov 2026
- latest of these filings; the earliest 12 Feb 2025
- Managers listing it
- 11
- at least, of 95 tracked, among listed positions
- Comparable managers
- 94
- filed both Q3 2024 and Q4 2024; 10 listed it in both
- Shares listed
- 72,343,478
- combined, among listed positions
- Reported value
- $2.0bn
- combined, at the quarter end
Among the 94 comparable managers: 4 buyers (opened or added shares) and 7 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing GEN in Q4 2024
11 of 11 holders
Largest increases and reductions, by shares
Increases
- Arrowstreet Capital LPexisting position · 1,948,353 shares now+918,982
- AQR Capital Management LLCexisting position · 2,370,575 shares now+349,633
- ExodusPoint Capital Management LPnew position · 281,472 shares now+281,472
- Tudor Investment Corpexisting position · 524,369 shares now+161,065
Reductions
- Fidelity (FMR LLC)existing position · 31,866,657 shares now-5,840,213
- AllianceBernstein LPexisting position · 7,441,026 shares now-2,663,927
- Bridgewater Associates LPexisting position · 304,248 shares now-213,343
- Neuberger Berman Group LLCexisting position · 2,356,761 shares now-163,858
- T. Rowe Price Associates Incexisting position · 7,645,523 shares now-63,109
New positions and exits
New (1)
Exited (1)
- Caxton Associates LLPwas $1.0m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q3 2019 | 1 | $48m | n.a. | n.a. |
| Q4 2019 | 23 | $4.2bn | n.a. | n.a. |
| Q1 2020 | 19 | $2.9bn | n.a. | n.a. |
| Q2 2020 | 16 | $3.0bn | n.a. | n.a. |
| Q3 2020 | 15 | $3.3bn | n.a. | n.a. |
| Q4 2020 | 14 | $3.3bn | n.a. | n.a. |
| Q1 2021 | 16 | $3.3bn | n.a. | n.a. |
| Q2 2021 | 20 | $4.4bn | n.a. | n.a. |
| Q3 2021 | 17 | $4.2bn | n.a. | n.a. |
| Q4 2021 | 18 | $3.9bn | n.a. | n.a. |
| Q1 2022 | 12 | $3.7bn | n.a. | n.a. |
| Q2 2022 | 17 | $2.4bn | n.a. | n.a. |
| Q3 2022 | 11 | $1.7bn | n.a. | n.a. |
| Q4 2022 | 11 | $1.7bn | n.a. | n.a. |
| Q1 2023 | 9 | $1.4bn | n.a. | n.a. |
| Q2 2023 | 12 | $1.7bn | n.a. | n.a. |
| Q3 2023 | 12 | $1.6bn | n.a. | n.a. |
| Q4 2023 | 14 | $2.1bn | 9 | 4 |
| Q1 2024 | 12 | $2.3bn | 8 | 4 |
| Q2 2024 | 12 | $2.5bn | 5 | 8 |
| Q3 2024 | 12 | $2.2bn | 6 | 6 |
| Q4 2024 | 11 | $2.0bn | 4 | 7 |
| Q1 2025 | 10 | $2.0bn | 6 | 2 |
| Q2 2025 | 10 | $2.1bn | 7 | 3 |
| Q3 2025 | 8 | $1.9bn | 4 | 4 |
| Q4 2025 | 9 | $1.9bn | 18 | 11 |
| Q1 2026 | 7 | $1.4bn | 19 | 16 |
| Q2 2026 | 6 | $1.7bn | 13 | 20 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
GEN and GOOGL →GEN and AMZN →GEN and MSFT →Choose a stock to compare with GEN →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own GEN, latest filings →Back to the 13F Explorer →